Loading
companiesCompany
Hologic
The women's health company behind most 3D mammography machines, HPV and cytology testing, and the Breast Cancer Index.
Overview
Hologic's Selenia Dimensions was the first digital breast tomosynthesis system approved by the FDA (2011). Its diagnostics arm sells the Aptima HPV assay and ThinPrep cytology, and the Genius Digital Diagnostics AI cytology system; it acquired Biotheranostics (Breast Cancer Index) in 2021. In 2025 Hologic agreed to be taken private by Blackstone and TPG.
Headquarters
Marlborough, MA, US
Scorecard
All companies#214of 1244 companies, score 25
- modalities +2
- registry trials +23
0 approved, 0 in phase 3, 0 earlier, 0 targets, 127 registry studies. Formula on the scorecards page.
Type
Devices & RT hardware · HOLX
Stage
Public
Website
Founded
1985
EstablishedGene-expression prognostic and predictive assay (extended endocrine therapy benefit)
Breast Cancer Index · Breast Cancer Index (BCI)
The only test designed to tell a woman who has finished five years of hormone therapy whether another five years is worth the side effects.
Similar pages
- TechnologyAI-assisted mammography screening
Shares Contrast-enhanced mammography, Mammography & tomosynthesis, HR-positive / HER2-negative breast cancer.
- CompanyFUJIFILM Healthcare
Shares Contrast-enhanced mammography, Elastography and contrast-enhanced ultrasound, Mammography & tomosynthesis.
- CompanyMobileODT
- TreatmentEndoPredict
Shares Breast Cancer Index, HR-positive / HER2-negative breast cancer.
- IdeaAfter the COMET trial: surveillance pathways and a new name for low-risk DCIS
Shares Mammography & tomosynthesis, HR-positive / HER2-negative breast cancer.
- CompanyTherapixel
Shares Mammography & tomosynthesis, HR-positive / HER2-negative breast cancer.
- CompanyVara
Shares Mammography & tomosynthesis, HR-positive / HER2-negative breast cancer.
- TechnologyHand-held and point-of-care ultrasound
Shares Elastography and contrast-enhanced ultrasound, HPV DNA testing and self-sampling, Mammography & tomosynthesis, Cervical cancer.
cancers
fronts
technologies
drugs
EstablishedGene-expression prognostic and predictive assay (extended endocrine therapy benefit)
Breast Cancer Index · Breast Cancer Index (BCI)
Software in use
The software of oncology →Commercial and regulated products that this organisation sells. Each card says what is behind it: a regulator's database, the literature, a public body's list, or only the company's own words. Listing is not endorsement, and a clearance is a regulatory fact, not a clinical one.
Hologic's detection algorithm for its own tomosynthesis systems, marking lesions and ranking cases for the reader.